BRAF and malignant colon neoplasm: On the other hand, treatments with AKT only inhibitor (GDC0941) or MTOR inhibitor (Rapamycin) reduced cell viability in all three treated mutant BRAF colon cancer cell lines in a similar way (Figure 3C).